Tokyo Tape
Sign in
← Euglena

Annual report

2931.TEDINET S100QG7X
Period2022-01-01 → 2022-12-31
Filed2023-03-27
StandardJapan GAAP
ConsolidatedYes
Data checks21 of 22 passed
Key figures · 64
MetricValuePeriodScopeSource row
Revenue¥44.4bn2022-01-01 → 2022-12-31Cons.Net sales
Revenue¥34.4bn2020-10-01 → 2021-12-31Cons.Net sales
Operating income−¥3.5bn2022-01-01 → 2022-12-31Cons.Operating income
Operating income−¥6.6bn2020-10-01 → 2021-12-31Cons.Operating income
Ordinary income−¥2.5bn2022-01-01 → 2022-12-31Cons.Ordinary income
Ordinary income−¥6.4bn2020-10-01 → 2021-12-31Cons.Ordinary income
Profit before tax−¥2.4bn2022-01-01 → 2022-12-31Cons.Income before income taxes
Profit before tax−¥6.7bn2020-10-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)−¥2.7bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥5.0bn2020-10-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income−¥2.7bn2022-01-01 → 2022-12-31Cons.Profit loss
Net income−¥5.8bn2020-10-01 → 2021-12-31Cons.Profit loss
Total assets¥57.3bnat 2022-12-31Cons.Assets
Total assets¥61.0bnat 2021-12-31Cons.Assets
Total liabilities¥37.9bnat 2022-12-31Cons.Liabilities
Total liabilities¥40.4bnat 2021-12-31Cons.Liabilities
Net assets / equity¥19.4bnat 2022-12-31Cons.Net assets
Net assets / equity¥20.6bnat 2021-12-31Cons.Net assets
Cash and deposits¥10.0bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥9.9bnat 2021-12-31Cons.Cash and deposits
Cash & equivalents¥9.8bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥9.8bnat 2021-12-31Cons.Cash and cash equivalents
Operating cash flow¥924m2022-01-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥1.4bn2020-10-01 → 2021-12-31Cons.Net cash provided by used in operating activities
Investing cash flow¥1.2bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥10.3bn2020-10-01 → 2021-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥3.0bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥12.1bn2020-10-01 → 2021-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥-23.832022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-49.072020-10-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
Net assets per share¥167.34at 2022-12-31Cons.Net assets per share (5-year summary)
Net assets per share¥181.35at 2021-12-31Cons.Net assets per share (5-year summary)
Equity ratio33.0%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio33.0%at 2021-12-31Cons.Equity to asset ratio (5-year summary)
Employees865at 2022-12-31Cons.Number of employees
Employees883at 2021-12-31Cons.Number of employees
Revenue¥6.5bn2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥9.5bn2020-10-01 → 2021-12-31StandaloneNet sales
Operating income−¥3.5bn2022-01-01 → 2022-12-31StandaloneOperating income
Operating income−¥3.4bn2020-10-01 → 2021-12-31StandaloneOperating income
Ordinary income−¥2.2bn2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income−¥2.6bn2020-10-01 → 2021-12-31StandaloneOrdinary income
Profit before tax−¥2.6bn2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Profit before tax−¥2.7bn2020-10-01 → 2021-12-31StandaloneIncome before income taxes
Net income−¥2.7bn2022-01-01 → 2022-12-31StandaloneProfit loss
Net income−¥2.4bn2020-10-01 → 2021-12-31StandaloneProfit loss
Total assets¥26.7bnat 2022-12-31StandaloneAssets
Total assets¥27.8bnat 2021-12-31StandaloneAssets
Total liabilities¥5.2bnat 2022-12-31StandaloneLiabilities
Total liabilities¥5.5bnat 2021-12-31StandaloneLiabilities
Net assets / equity¥21.5bnat 2022-12-31StandaloneNet assets
Net assets / equity¥22.3bnat 2021-12-31StandaloneNet assets
Cash and deposits¥2.9bnat 2022-12-31StandaloneCash and deposits
Cash and deposits¥4.9bnat 2021-12-31StandaloneCash and deposits
EPS (basic)¥-23.92022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-22.942020-10-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥186.11at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥197.18at 2021-12-31StandaloneNet assets per share (5-year summary)
Equity ratio78.8%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio78.8%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Shares issued113,105,455at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued111,161,886at 2021-12-31StandaloneTotal number of issued shares (5-year summary)
Employees250at 2022-12-31StandaloneNumber of employees
Employees212at 2021-12-31StandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2022-01-01 → 2022-12-31¥1m
Reconciling Itemsreconcilingdepreciation2022-01-01 → 2022-12-31¥50m
Reconciling Itemsreconcilingsegment assetsat 2022-12-31¥3.4bn
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-12-31−¥1.7bn
Biofuel Businessreportable segmentcapex2022-01-01 → 2022-12-31¥22m
Biofuel Businessreportable segmentdepreciation2022-01-01 → 2022-12-31¥49m
Biofuel Businessreportable segmentemployeesat 2022-12-3143 pure
Biofuel Businessreportable segmentrevenue2022-01-01 → 2022-12-31¥262m
Biofuel Businessreportable segmentrevenue external2022-01-01 → 2022-12-31¥262m
Biofuel Businessreportable segmentsegment assetsat 2022-12-31¥947m
Biofuel Businessreportable segmentsegment profit2022-01-01 → 2022-12-31−¥789m
Health Care Businessreportable segmentcapex2022-01-01 → 2022-12-31¥406m
Health Care Businessreportable segmentdepreciation2022-01-01 → 2022-12-31¥2.2bn
Health Care Businessreportable segmentemployeesat 2022-12-31655 pure
Health Care Businessreportable segmentrevenue2022-01-01 → 2022-12-31¥41.6bn
Health Care Businessreportable segmentrevenue external2022-01-01 → 2022-12-31¥41.6bn
Health Care Businessreportable segmentsegment assetsat 2022-12-31¥49.6bn
Health Care Businessreportable segmentsegment profit2022-01-01 → 2022-12-31−¥638m
Others Businessreportable segmentcapex2022-01-01 → 2022-12-31¥48m
Others Businessreportable segmentdepreciation2022-01-01 → 2022-12-31¥34m
Others Businessreportable segmentemployeesat 2022-12-31113 pure
Others Businessreportable segmentrevenue2022-01-01 → 2022-12-31¥2.5bn
Others Businessreportable segmentrevenue external2022-01-01 → 2022-12-31¥2.5bn
Others Businessreportable segmentsegment assetsat 2022-12-31¥3.3bn
Others Businessreportable segmentsegment profit2022-01-01 → 2022-12-31−¥325m
—segment totalcapex2022-01-01 → 2022-12-31¥477m
—segment totaldepreciation2022-01-01 → 2022-12-31¥2.3bn
—segment totalrevenue2022-01-01 → 2022-12-31¥44.4bn
—segment totalrevenue external2022-01-01 → 2022-12-31¥44.4bn
—segment totalsegment assetsat 2022-12-31¥53.9bn
—segment totalsegment profit2022-01-01 → 2022-12-31−¥1.8bn
Reconciling Itemsreconcilingcapex2020-10-01 → 2021-12-31¥31m
Reconciling Itemsreconcilingdepreciation2020-10-01 → 2021-12-31¥94m
Reconciling Itemsreconcilingsegment assetsat 2021-12-31¥5.7bn
Reconciling Itemsreconcilingsegment profit2020-10-01 → 2021-12-31−¥2.2bn
Biofuel Businessreportable segmentcapex2020-10-01 → 2021-12-31¥37m
Biofuel Businessreportable segmentdepreciation2020-10-01 → 2021-12-31¥110m
Biofuel Businessreportable segmentrevenue2020-10-01 → 2021-12-31¥47m
Biofuel Businessreportable segmentrevenue external2020-10-01 → 2021-12-31¥47m
Biofuel Businessreportable segmentsegment assetsat 2021-12-31¥602m
Biofuel Businessreportable segmentsegment profit2020-10-01 → 2021-12-31−¥1.2bn
Health Care Businessreportable segmentcapex2020-10-01 → 2021-12-31¥387m
Health Care Businessreportable segmentdepreciation2020-10-01 → 2021-12-31¥1.5bn
Health Care Businessreportable segmentrevenue2020-10-01 → 2021-12-31¥33.7bn
Health Care Businessreportable segmentrevenue external2020-10-01 → 2021-12-31¥33.7bn
Health Care Businessreportable segmentsegment assetsat 2021-12-31¥52.1bn
Health Care Businessreportable segmentsegment profit2020-10-01 → 2021-12-31−¥2.8bn
Others Businessreportable segmentcapex2020-10-01 → 2021-12-31¥54m
Others Businessreportable segmentdepreciation2020-10-01 → 2021-12-31¥14m
Others Businessreportable segmentrevenue2020-10-01 → 2021-12-31¥627m
Others Businessreportable segmentrevenue external2020-10-01 → 2021-12-31¥627m
Others Businessreportable segmentsegment assetsat 2021-12-31¥2.6bn
Others Businessreportable segmentsegment profit2020-10-01 → 2021-12-31−¥373m
—segment totalcapex2020-10-01 → 2021-12-31¥479m
—segment totaldepreciation2020-10-01 → 2021-12-31¥1.6bn
—segment totalrevenue2020-10-01 → 2021-12-31¥34.4bn
—segment totalrevenue external2020-10-01 → 2021-12-31¥34.4bn
—segment totalsegment assetsat 2021-12-31¥55.3bn
—segment totalsegment profit2020-10-01 → 2021-12-31−¥4.4bn
Biofuel Businessreportable segmentemployeesat 2022-12-3143 pure
Health Care Businessreportable segmentemployeesat 2022-12-31127 pure
Others Businessreportable segmentemployeesat 2022-12-3125 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,625
ItemContextValueUnit
Cash and cash equivalentsPrior2YearInstant6253000000JPY
Cash and cash equivalentsPrior1YearInstant9820000000JPY
Increase in cash and cash equivalents resulting from share exchangesPrior1YearDuration455000000JPY
Increase in cash and cash equivalents resulting from share exchangesCurrentYearDuration825000000JPY
Increase decrease in cash and cash equivalents resulting from change of scope of consolidation ccePrior1YearDuration4000000JPY
Increase decrease in cash and cash equivalents resulting from change of scope of consolidation cceCurrentYearDuration－JPY
Cash and cash equivalentsPrior1YearInstant9820000000JPY
Cash and cash equivalentsCurrentYearInstant9814000000JPY
Number of consolidated subsidiariesCurrentYearInstant15
Number of unconsolidated subsidiaries and associates accounted for using equity methodCurrentYearInstant3
Advertising expenses sgaPrior1YearDuration8992000000JPY
Advertising expenses sgaCurrentYearDuration11142000000JPY
Packing and transportation expenses sgaPrior1YearDuration2967000000JPY
Packing and transportation expenses sgaCurrentYearDuration4205000000JPY
Promotion expenses sgaPrior1YearDuration2638000000JPY
Promotion expenses sgaCurrentYearDuration2846000000JPY
Salaries and allowances sgaPrior1YearDuration2415000000JPY
Salaries and allowances sgaCurrentYearDuration2935000000JPY
Research and development expenses sgaPrior1YearDuration1752000000JPY
Research and development expenses sgaCurrentYearDuration1480000000JPY
Depreciation sgaPrior1YearDuration1196000000JPY
Depreciation sgaCurrentYearDuration1941000000JPY
Provision of allowance for doubtful accounts sgaPrior1YearDuration27000000JPY
Provision of allowance for doubtful accounts sgaCurrentYearDuration45000000JPY
Provision for bonuses sgaPrior1YearDuration189000000JPY
Provision for bonuses sgaCurrentYearDuration240000000JPY
Research and development expenses sgaPrior1YearDuration1752000000JPY
Research and development expenses sgaCurrentYearDuration1480000000JPY
Write downs of inventoriesPrior1YearDuration235000000JPY
Write downs of inventoriesCurrentYearDuration117000000JPY
Revenues from external customersPrior1YearDuration_jpcrp030000-asr_E27054-000HealthCareBusinessReportableSegmentsMember33745000000JPY
Revenues from external customersPrior1YearDuration_jpcrp030000-asr_E27054-000BiofuelBusinessReportableSegmentsMember47000000JPY
Revenues from external customersPrior1YearDuration_jpcrp030000-asr_E27054-000OthersBusinessReportableSegmentsMember627000000JPY
Revenues from external customersPrior1YearDuration_ReportableSegmentsMember34420000000JPY
Revenues from external customersPrior1YearDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YearDuration34420000000JPY
Transactions with other segmentsPrior1YearDuration_jpcrp030000-asr_E27054-000HealthCareBusinessReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YearDuration_jpcrp030000-asr_E27054-000BiofuelBusinessReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YearDuration_jpcrp030000-asr_E27054-000OthersBusinessReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YearDuration_ReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YearDuration_ReconcilingItemsMember－JPY
Transactions with other segmentsPrior1YearDuration－JPY
Net salesPrior1YearDuration_jpcrp030000-asr_E27054-000HealthCareBusinessReportableSegmentsMember33745000000JPY
Net salesPrior1YearDuration_jpcrp030000-asr_E27054-000BiofuelBusinessReportableSegmentsMember47000000JPY
Net salesPrior1YearDuration_jpcrp030000-asr_E27054-000OthersBusinessReportableSegmentsMember627000000JPY
Net salesPrior1YearDuration_ReportableSegmentsMember34420000000JPY
Net salesPrior1YearDuration_ReconcilingItemsMember－JPY
Net salesPrior1YearDuration34420000000JPY
Operating incomePrior1YearDuration_jpcrp030000-asr_E27054-000HealthCareBusinessReportableSegmentsMember-2761000000JPY
Operating incomePrior1YearDuration_jpcrp030000-asr_E27054-000BiofuelBusinessReportableSegmentsMember-1229000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 22 passed
balance sheet identityconsolidated 2021-12-31pass rounding
balance sheet identityconsolidated 2022-12-31pass rounding
balance sheet identitynon_consolidated 2021-12-31pass
balance sheet identitynon_consolidated 2022-12-31pass rounding
dei present pass
period resolution partial
statement vs summary · net assetsconsolidated 2021-12-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2020-10-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2020-10-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-12-31pass
statement vs summary · revenueconsolidated 2020-10-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2020-10-01/2021-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2021-12-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2021-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass